AzTrials
AzTrials

Prosthesis SurvivalNCT06422260

Four-unit Implant Supported Fixed Partial Dentures Fabricated From Different Materials

An observational study of Prosthesis Survival and Bone Loss, run by Menoufia University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Implant supported superstructure is necessary for long term success and durability of the implant itself in terms of stresses distribution and fracture strength capability. Stresses falling on an implant are too much greater than those applied on a tooth structure with a periodontal ligament offering a degree of… Read more about this study

Who is it for?
Ages 30 to 50 years
Conditions the study is for
Prosthesis Survival, Bone Loss
What is being tested?
Prosthesis superstructure
How many people
60 participants
Where
1 siteEgypt
Study dates
19 Jan 2023to 29 Jan 2025
How long will I take part?
4 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 50 years
  • All sexes
  • Adult

Study population: 60 participants who needed an implant-supported fixed partial denture (FPD) in the esthetic zone.

Who may be able to join

  • No systemic diseases that might alter the tissue response to implantation.
  • Mobility grade 3 at the site of the 4 lateral incisors.
  • sufficient available inter-arch space
  • normal maxillomandibular relation.
  • no temporomandibular joint

Who cannot join

  • Grade 1 or 2 mobility at the incisor's region.
  • Patients with systematic diseases that contraindicate implant placement.

Trial locations and contacts

1 site in 1 country.

Mohammed A. El-Sawy, PhD contact

01061314522

Dr_sawy@windowslive.com

Mohammed T. Khater, PhD contact

01003854552

mohamed.tarek67@dent.menofia.edu.eg

Egypt1 site, 1 recruiting
  • Mohammed A. El-Sawy

    Al Mansurah, 12345

    Mohammed A. El-Sawy, 161314522, Dr_sawy@windowslive.com

    Recruiting

Other trials in Egypt

About this study

Official title: Clinical and Radiographic Outcomes of Four-unit Implant Supported Fixed Partial Dentures Fabricated From Different Materials

Implant supported superstructure is necessary for long term success and durability of the implant itself in terms of stresses distribution and fracture strength capability. Stresses falling on an implant are too much greater than those applied on a tooth structure with a periodontal ligament offering a degree of elasticity. The important mechanical and physical properties of materials used for the fabrication of dental prostheses include adequate flexural and tensile strength and modulus of elasticity, maximum fracture resistance, optimal bond strength and adequate polishability.

Read the detailed description

One objective of implant dentistry is to provide excellent esthetics and soft-tissue profiles in the esthetic zone. Esthetic requirements have focused primarily on the position, inclination, shape, and color of the restoration. However, the peri-implant soft tissue also plays a major role in the esthetics of an implant-supported restoration especially in the anterior region.

Being tested
Prosthesis superstructure
Medical subject headings
Prosthesis Failure, Bone Diseases, Metabolic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prosthesis superstructureOther

    Prosthesis superstructure for 2 implant supported short span fixed bride constructed from different materials

Study groups in NCT06422260
Study groupRoleWhat they receive
Porcelin fused to metal (PFM) groupEvaluation of biological response and clinical performance of the fixed partial denture anterior bridge constructed from PFM
Receives: Other: Prosthesis superstructure
Zirconia groupEvaluation of biological response and clinical performance of the fixed partial denture anterior bridge constructed from ceramics
Receives: Other: Prosthesis superstructure
Polyetheretherketone (PEEK) groupEvaluation of biological response and clinical performance of the fixed partial denture anterior bridge constructed from PEEK
Receives: Other: Prosthesis superstructure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone loss

    Measurement of alveolar bone loss around implants.

    Measured: 4 years

Secondary outcomes (1)
  1. Clinical performance of the prosthesis superstructure

    Such as fracture of the prosthesis.

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2024
  2. Study start19 Jan 2023
  3. Primary completion22 Jul 2024 (estimated)
  4. Study completion29 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
Target duration
4 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT06422260
Sponsor's protocol ID
ADMNF-0030324
Status last verified
May 2024
First submitted
8 May 2024
Last updated
20 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The result can be shared upon request from the corresponding author

Questions about this trial

What is this clinical trial studying?

An observational study of Prosthesis Survival and Bone Loss, run by Menoufia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohammed A. El-Sawy, PhD (01061314522, Dr_sawy@windowslive.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone loss (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in